Darzalex (daratumumab)

daratumumab · Janssen Biotech, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Darzalex (daratumumab), covering 2023-02-08 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma [Phase 2]

See pricing